Episode 50: Genetic Testing for Huntington Disease
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Victor Sung, MD.
Episode 50 of the NeurologyLive
The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis (MS), Parkinson disease, dementia, sleep disorders, and more.
Episode 50, "Genetic Testing for Huntington Disease" features an exclusive interview with Victor Sung, MD, director, UAB Huntington's Disease Clinic, codirector, UAB School of Medicine Neuroscience Module, and director, Birmingham VAMC Deep Brain Stimulation Program. Sung detailed data on the cost of genetic testing in HD that he and colleagues presented earlier this year at the
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
Cerezen Device Gets Breakthrough Designation in Alzheimer Disease, MCI Amylyx Submits New Drug Application for ALS Treatment AMX0035 Eli Lilly Initiates Rolling Submission for Donanemab in Early Alzheimer Disease
EPISODE BREAKDOWN
1:45 – Background on the genetic testing process
3:50 – Findings of the study presented at MDS 2021
7:30 – Future plans to evaluate genetic testing costs
11:30 – Current utilization of genetic testing for HD
14:10 – Neurology News Minute
18:05 – Raising awareness for genetic testing
21:25 – Biggest step forward in Huntington disease
25:10 – Takeaways from MDS 2021
REFERENCE
Massey M, Orem T, Sung V. Cost of Predictive Genetic Testing for Huntington’s Disease at Centers of Excellence in the US. Presented at: MDS Congress 2021; September 17-22; Virtual. Poster 240.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
Pathophysiology of Myasthenia GravisSeptember 18th 2025
